Excluded Evidence Could Revive Pa. Paxil Case On Appeal
By Matt Fair ( April 5, 2016, 10:23 PM EDT) -- A decision to bar key deposition testimony and grant the midtrial dismissal of a Pennsylvania case against GlaxoSmithKline PLC over alleged birth defects from the antidepressant Paxil could be upended on appeal over concerns that a judge improperly limited evidence of stronger warnings later adopted for the drug....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.